Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#Methotrexate ×
Actualizaciones regulatorias
25 sept 2026•1 min de lectura
FDA Discontinues FOLEX Injectable Methotrexate Products (ANDA087695)
The FDA's ANDA087695 filing for FOLEX injectable methotrexate (25 mg, 50 mg, 100 mg) shows all three products are listed as discontinued.
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Discontinues Methotrexate Sodium Injection (ANDA089309)
The FDA has listed Quad Pharms' methotrexate sodium injection (product 001) as discontinued under ANDA089309.